In an interview with PharmaShots, Martina Flammer, Chief Medical Officer at Insmed share her views on the R&D continuum to develop new drugs for rare diseases and also highlights its business pillars
Shots:
The idea of the continuum is that all department works together to develop the drugs which will be helpful not only for the company but for patients too
In…
